新股暗盤 | 聯易融科技-W(9959.HK)暗盤段漲5%
格隆匯4月8日丨據富途證券,聯易融科技-W(9959.HK)暗盤段現報18.46港元,較發行價17.58港元漲5%。公司是一家領先的供應鏈金融科技解決方案提供商,2018年至2020年收益分別為3.82億、6.99億、10.28億元人民幣,每股有形資產淨值4.32-4.71港元。此次上市全球發售約4.53億股,其中香港發售約1.268億股,國際發售3.26億股,每手500股,一手中籤率20%,香港發售股份獲98.46倍認購,淨籌77.138億港元,當中35%將用於增強公司的核心科技能力和基礎研究與開發。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.